Common use of Terms Defined Elsewhere Clause in Contracts

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: 401(k) Plan Section hereof in which such term is defined: 5.07(d) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 5.03(d)(i) Book-Entry Shares Section 4.7 Books and Records 2.02(b) Capitalization Date Section 2.12(f)(23.02(a) Claim Notice Certificate of Merger Section 8.3(a1.02 Certificates Section 2.02(b) Change of Board Recommendation Section 5.03(a)(v) Closing Section 2.3 1.02 Closing Date Section 2.3 1.02 Company Preamble Company Common Stock Section 2.8 Board Recitals Company Board Recommendation Recitals Company Disclosure Schedule Article IV ARTICLE III Company Expenses Schedule Employees Section 2.13 5.07(a) Company Indemnified Parties Financial Statements Section 8.2(a)(ii3.07(a) Contracts Company Material Contract Section 4.8(a3.13(a) Covered Party (PartiesCompany Permits Section 3.05(a) Company Preferred Stock Section 8.2(a)(ii3.02(a) Damages Company Representatives Section 8.2(a)(i5.02(a) Company SEC Documents Section 3.06(a) Company Stockholder Approval Section 3.21 Confidentiality Agreement Section 5.02(c) D&O Indemnification Agreements Section 5.08(a) D&O Runoff Insurance Section 5.08(c) DGCL Recitals Dispute Section 2.1 Document Retention Period 3.15(l) Dissenting Shares Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 2.03 Effective Time Section 2.2 ERISA 1.02 Electronic Delivery Section 4.13(a8.13 Employment Practices Section 3.12(a) ERISA Affiliate Exon-Xxxxxx Filing Section 4.13(a5.04(c) Finally Determined Export Approvals Section 8.5(b3.05(e) First Milestone Full Value Award Section 2.10(e2.04(b) First Milestone Payment Fundamental Representations Section 6.02(a)(ii) Guarantee Section 8.15(c) Guaranteed Obligations Section 8.15(a) Guarantor Section 8.15(a) Indentures Section 5.14 Independent Director Section 3.12(h) Insurance Policies Section 3.17 Intercompany Contracts Section 3.13(a)(vii) Intervening Event Notice Period Section 5.03(e)(i) Leased Real Property Section 3.18(c) LGPL Section 3.15(f) Maximum Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c5.08(c) Merger Section 2.1 Recitals Merger Certificate Section 2.2 Consideration Recitals Merger Sub Preamble Most Recent Balance Sheet Section 3.09(a)(i) New Plans Section 5.07(a) Parent Preamble Parent Disclosure Schedule Article V Representatives Section 5.02(a) Parent Indemnified Parties Subsidiary Section 8.2(a)(i4.03(a) parties Preamble Payee Parent Welfare Plan Section 8.5 Payor 5.07(a) Paying Agent Section 8.5 Per Diem Taxes 2.02(a) Proxy Statement Section 8.7(a1.03(a) Proceeding Replacement Right Section 4.17 Royalties 2.04(b) Xxxxxxxx-Xxxxx Act Section 2.10(h3.06(a) Second Milestone Section 2.10(f16 Section 5.10 Shares Recitals Significant Customer Section 3.23 Special Meeting Section 1.03(e) Second Milestone Payment Amount Superior Proposal Notice Period Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b5.03(d)(i) Surviving Corporation Recitals Takeover Law Section 2.1 Third Milestone 3.03(b) Termination Fee Section 2.10(g7.02(b) Third Milestone Payment Amount U.S. Continuing Employees Section 2.10(g5.07(a) Voting Agreement Recitals WARN Act Section 3.12(e) Worker List Section 3.12(f)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: 1.1(e) Aggregate Xxxxxx Payable Amount Section 1.1(f)(iii) Agreement Preamble Biogen Idec License Agreement Bankruptcy Cases Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 5.9 Company Preamble Company Common Stock Section 2.8 Board of Directors Recitals Company Board Recommendation Recitals Company Disclosure Schedule Letter Article IV II Company Expenses Schedule Party Section 2.13 1.1(f)(iii) Company Shares Recitals D&O Insurance Section 5.4(c) Enforceability Limitations Section 2.3(b) Equity Award Cash Consideration Section 1.1(h) Equity Award Xxxxxx Payment Section 1.1(h) Exculpation and Indemnification Agreements Section 5.4(b) Indemnified Parties Section 8.2(a)(ii5.4(a) Contracts Xxxxxx Section 4.8(a1.1(f)(iii) Covered Xxxxxx Claim Section 1.1(f)(iii) Offer Recitals Offer Conditions Section 1.1(a)(iv) Offer to Purchase Section 1.1(a)(iii) Outside Date Section 6.1(d) Party (PartiesPreamble Per Member Xxxxxx Payable Amount Section 1.1(f)(i) Per Share Xxxxxx Payable Amount Section 8.2(a)(ii1.1(f)(ii) Damages Process Agent Section 8.2(a)(i7.9(c) DGCL Prospector Rig Acquisition Section 2.1 Document Retention 5.9 Purchaser Preamble Purchaser Disclosure Letter Article III Tail Period Section 2.12(f)(25.4(c) Drug Regulatory Agency Tender Offer Consideration Section 4.25 Effective 1.1(a)(ii) Tendering Members Recitals Termination Payment Section 6.2(b) *Percentages are rounded off to the nearest second decimal point and are calculated based on 5,017,556 total outstanding Shares as of the date hereof. Xx the date falling 5 days before the agreed date for the Acceptance Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)and again immediately prior to the Acceptance Time, the Company shall provide Purchaser with responses to each of the following inquiries from the rig manager of each of the Prospector Rigs via electronic mail (from a company or ship email address):

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms (as capitalized below) will have the following meanings when used in this Agreement and a reference to the Agreement: Action Section hereof in which such term is defined: 6.10(b) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.04(a) Alternative Proposal Section 4.7 Books and Records 6.04(i) Annual Bonus Section 2.12(f)(26.06(e) Claim Notice Approval Request Section 8.3(a6.01(b) Articles of Merger Section 2.03 Book-Entry Shares Section 3.01(a) Burdensome Condition Section 6.07(d) Capex Budget Section 4.13(a)(i) Certificate of Merger Section 2.03 Certificates Section 3.01(a) Change of Recommendation Section 6.04(f) Closing Section 2.3 2.02 Closing Date Section 2.3 2.02 Code Section 3.02(b)(iii) Common Stock Section 3.01(a) Company Preamble Company Common Stock Section 2.8 Board Recitals Company Disclosure Schedule Letter Article IV Company Expenses Schedule Employee Section 2.13 6.06(a) Company Indemnified Employees Section 6.06(a) Company Incentive Plan Section 6.06(e) Company Product Section 4.21 Company Related Parties Section 8.2(a)(ii8.03(a) Contracts Company SEC Reports Section 4.8(a4.06(a) Covered Party (PartiesCompany Shareholders’ Meeting Section 6.05(b) Confidentiality Agreement Section 8.2(a)(ii6.03(b) Damages control Definition of Affiliates, Section 8.2(a)(i) 1.01 controlled by Definition of Affiliates, Section 1.01 DGCL Section 2.1 Document Retention Period 2.01 Dissenting Shares Section 2.12(f)(23.01(c)(ii) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.03 End Date Section 8.01(b) Enforcement Expenses Section 8.03(b) Exchange Fund Section 3.02(a) First Extended Date Section 8.01(b) Gxxxxxx Sxxxx Section 4.25 Indemnified Party Section 6.10(b) Intervening Event Section 6.04(k) Intervening Event Notice Section 6.04(g) Leases Section 4.10(b) Legal Restraint Section 7.01(b) Mass Layoff Section 4.18(a) Material Contract Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Maximum Amount Section 2.10(e6.10(c) Indemnifying Party Measurement Time Section 8.3(a) Instrument Section 2.12(c4.02(a) Merger Recitals Merger Consideration Section 2.1 Merger Certificate Section 2.2 3.01(a) Merger Sub Preamble Multiemployer Plan Section 4.18(j) New Plans Section 6.06(b) Notice Period Section 6.04(f) OFAC Definition of Sanctions, Section 1.01 Old Plans Section 6.06(b) Oregon Act Section 2.01 Owned Real Property Section 4.10(a) Parent Preamble Parent Disclosure Schedule Article V Material Adverse Effect Section 5.01 Parent Indemnified Related Parties Section 8.2(a)(i8.03(a) parties Parties Preamble Payee Party Preamble Paying Agent Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a3.02(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Payoff Amount Section 2.10(f6.18 Payoff Letter Section 6.18 Plant Closing Section 4.18(a) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority President Definition of CFIUS Approval, Section 2.12(b1.01 Recommendation Section 4.04 Remedial Action Section 6.07(d) Replacement Credit Facility Section 6.01(a)(x)(A)(v) Required Company Shareholder Vote Section 4.24 Sanctioned Countries Definition of Sanctions Target, Section 1.01 Share Section 3.01(a) Significant Customers Section 4.22 Significant Suppliers Section 4.22 Specified Regulatory Approvals Section 7.01(c) Superior Proposal Section 6.04(j) Superior Proposal Notice Section 6.04(f) Surviving Corporation Section 2.1 Third Milestone 2.01 Takeover Statutes Section 2.10(g4.23 Tax Proceeding Section 4.17(f) Third Milestone Payment Amount Tax Sharing Agreement Section 2.10(g4.17(l) Termination Date Section 6.01(a) under common control with Definition of Affiliates, Section 1.01 Union Employees Section 6.06(f) Voting Subsidiary Debt Section 4.03(d) WARN Act Section 4.18(a)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Action Section hereof in which such term is defined: 4.12 Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.4(c)(ii) Alternative Financing Section 4.7 Books 6.6(b) Alternative Financing Agreements Section 6.6(b) Anti-Corruption Laws Section 4.5(b) Articles of Merger Section 2.3 Bankruptcy and Records Equity Exception Section 2.12(f)(24.3(a) Claim Notice BVI Companies Act Preamble Certificates Section 8.3(a3.2(c)(i) Closing Section 2.3 2.2 Closing Date Section 2.3 2.2 Company Preamble Company Common Stock Adverse Recommendation Change Section 2.8 6.4(c)(i) Company Disclosure Schedule Article IV Board Preamble Company Expenses Schedule Financial Advisor Section 2.13 4.3(b) Company Financial Statements Section 4.6(b) Company Group Section 8.2(f)(i) Company Intellectual Property Section 4.14(b) Company Material Contract Section 4.11(b) Company Plan(s) Section 4.9(a) Company Recommendation Section 4.3(b) Company Representatives Section 6.3(a) Company SEC Filings Section 4.6(a) Company Shareholders Meeting Section 6.2(e)(i) Company Subsidiary Section 4.1 Company Workers Section 4.14(e) D&O Insurance Section 6.12(b) Debt Commitment Letter Section 5.6(a) Debt Financing Agreement Section 6.6(a) Dissenter Rights Section 3.1(e) Dissenting Shareholders Section 3.1(e) Dissenting Shares Section 3.1(e) Effective Time Section 2.3 End Date Section 8.1(b)(i) Exchange Fund Section 3.2(b) Financing Section 5.6(a) Financing Agreements Section 6.6(b) Guarantor Preamble HKIAC Section 9.7(b) Indemnified Parties Section 8.2(a)(ii6.12(a) Contracts Intervening Event Section 4.8(a6.4(e)(i) Covered Party (PartiesInvestments Section 4.2(d) Leased Real Property Section 8.2(a)(ii4.17(b) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Limited Guarantee Preamble Merger Section 2.1 Merger Certificate Section 2.2 Preamble Merger Sub Preamble Notice Period Section 6.4(d)(iii) Owned Real Property Section 4.17(a) Parent Preamble Parent Disclosure Group Section 8.2(f)(i) Parent Representatives Section 6.3(a) Party Preamble Paying Agent Section 3.2(a) Per Share Merger Consideration Section 3.1(b) Plan of Merger Section 2.3 PRC VIEs Section 4.21(a) Proxy Statement Section 6.2(a) Registrar of Companies Section 2.3 Rollover Securities Preamble Rollover Securityholder Preamble SAFE Rules and Regulations Section 4.5(c) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i4.4(b) parties Special Committee Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Support Agreement Preamble Super Majority Section 2.12(b) Surviving Corporation Company Section 2.1 Third Milestone Transaction Litigation Section 2.10(g) Third Milestone Payment Amount 6.8 Uncertificated Shares Section 2.10(g3.2(c)(i)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Acquired Assets Acquired Assets Permits Acquired Assets Regulatory Filings Aggregate Threshold Agreed Amount Agreement and a reference to the Antitrust Approvals Assigned Contracts Assigned IP Contracts Assumed Liabilities Assumption Agreements Bill of Sale Burdensome Term or Condition Section hereof in which such term is defined: Agreement 1.01(a) Section 2.12(a) Section 2.12(a) Section 6.05(b)(ii) Section 6.04 (b) Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement 4 .03(b) Section 4.7 Books and Records 1.01(a)(iv) Section 2.12(f)(21.01(a)(iv) Section 1.01(d) Section 1.01(d) Section 1.03(b)(iii) Section 4 .03(f) 49 Ame ric as 9 2 4 2 5 1 0 0 Buyer Preamble Buyer FDA Letter Section 5.03(e) Buyer Group Section 1.01(a) Buyer Indemnified Parties Section 6.02 Buyer Orphan Designation Letter Section 5.03(e) Cap Section 6.05(b)(i) CF Enterprise Recitals Claim Notice Section 8.3(a6.04 (b) Claimed Amount Section 6.04 (b) Closing Section 2.3 1.03(a) Closing Date Section 2.3 Company 1.03(a) Confidentiality Agreement Section 4 .02 Contingent Payment Section 1.02(b) CTAs Section 2.10(a)(viii) DOJ Section 4 .03(a) Electronic Delivery Section 10.07 Excluded Assets Section 1.01(b) Excluded Liabilities Section 1.01(e) FDA Section 2.12(a) FDCA Section 2.12(a) FTC Section 4 .03(a) Fundamental Representations Section 6.01(a) Guarantor Preamble Company Common Stock HSR Act Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.05(c) Indemnified Party Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party 6.04 (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(ea) Indemnifying Party Section 8.3(a6.04 (a) Instrument IP Assignment Agreements Section 2.12(c1.03(b)(iv) Merger Material Contract Section 2.1 Merger Certificate 2.10(a) MTAs Section 2.2 Merger Sub 2.10(a)(viii) NDAs Section 2.10(a)(viii) Non‑Compete Period Section 9.05(a) Outside Date Section 7.01(f)(ii) Parties Preamble Parent Party Preamble Parent PHSA Section 2.12(a) Pre‑Closing Period Section 4 .01(a) Research and Testing Agreement Recitals Registered Business IP Section 2.09(a) Regulatory Authority Section 2.12(a) Regulatory Filings Section 4 .03(a) Related Agreements Section 2.03 Restricted Names Section 9.02 Safety Notice Section 2.12(d) Ame ric as 9 2 4 2 5 1 0 0 Seller Preamble Seller Board Section 2.03 Seller Board Approval Section 2.20 Seller Change of Recommendation Section 4 .07(c) Seller Disclosure Schedule Letter Article V Parent II Seller FDA Letter Section 5.02(f) Seller Indemnified Parties Section 8.2(a)(i6.03 Seller Orphan Designation Letter Section 5.02(f) parties Preamble Payee Supplement Section 8.5 Payor 4 .04 Termination Fee Section 8.5 Per Diem 7.02(b) Third Party Claim Section 6.04 (a) Third Party IP Section 2.09(f) Transfer Taxes Section 8.7(a8.01(a) Proceeding Transferred IP Section 4.17 Royalties 1.01(a)(ii) Transferred IP Documentation Section 2.10(h1.01(a)(iii) Second Milestone Transferred Permits Section 2.10(f1.01(a)(vi) Second Milestone Payment Amount Transition Services Agreement Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g1.03(b)(vii)

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: A&R GGPPA Section 6.1(f) Acquired Entity Benefit Plan Section 3.14(a) Affiliate Transaction Section 3.21 Agreement Preamble Biogen Idec License Agreement Antitrust Laws Section 4.7 Biogen Idec Supply Agreement 6.2(c) Balance Sheet Date Section 4.7 Books and Records 3.5(a) Buyers Preamble Carlsbad CIV Preamble Casualty Loss Section 2.12(f)(2) Claim Notice Section 8.3(a) 6.4 Closing Section 2.3 2.4 Closing Date Section 2.3 Company 2.4 control Section 1.1 D&O Provisions Section 6.10(a) ECP III Preamble Company Common Stock ECP III CIV Preamble ECP III-A Preamble ECP III-B Preamble ECP III-C Preamble ECP Parties Preamble Excess Payment Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.3(f)(i) Final Adjustment Certificate Section 2.13 Company 2.3(d) Final Settlement Date Section 2.3(c) Financial Statements Section 3.5(a) First Lien Debt Payoff Amount Section 2.5(b)(iii)(C) General Partner Preamble GP Buyer Preamble GP Interests Recitals Guarantee Section 8.14(a) Guarantor Preamble Holdings Recitals Indemnified Persons Section 6.10(a) Intended Tax Treatment Section 2.6(a) Xxxxxx & Xxxxxxx Section 8.11(a) LP Buyer Preamble LP Interest Sellers Preamble LP Interests Recitals Material Contract Section 3.10(b) Maximum D&O Premium Section 6.10(a) MOP Section 6.1(f) Multiemployer Plan Section 3.14(a) New Plans Section 6.13 Non-Continuing Employee Section 6.13 Nonparty Affiliates Section 6.17 Notice of Disagreement Section 2.3(c) Outside Date Section 7.1(c) Partnership Preamble Partnership Proprietary Rights Section 3.11(a) Party and Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Preamble Purchase Price Section 2.2 ERISA Purchase Price Allocation Section 4.13(a2.6(b) ERISA Affiliate R&W Insurance Policy Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment 6.3 Second Lien Debt Payoff Amount Section 2.10(e2.5(b)(iii)(D) Indemnifying Party Seller Representative Section 8.3(a8.13(a) Instrument Seller Representative Expense Account Section 2.12(c8.13(c) Merger Seller Tax Returns Section 2.1 Merger Certificate 6.5(a) Sellers Preamble Sendero Carlsbad Finance Recitals Sendero Carlsbad Midstream Recitals Sendero Management Preamble Shortfall Payment Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties 2.3(f)(i) Subject Interests Recitals Tail Policy Section 8.2(a)(i6.10(a) parties Preamble Payee Tax Contest Section 8.5 Payor Section 8.5 Per Diem 6.5(c) Transfer Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g6.5(f)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: 280G Stockholder Approval Section hereof in which such term is defined: 5.6(b) 401(k) Plan Section 1.4(b)(i) Adjustment Resolution Period Section 1.15(b) Adjustment Review Period Section 1.15(b) Agreement Preamble Biogen Idec License Agreement Date Preamble Allocation Schedule Section 4.7 Biogen Idec Supply Agreement 4.3(a) Anti-Corruption Laws Section 4.7 2.24 Balance Sheet Date Section 2.7(b) Behavioral Data Section 2.12(a)(i) Board Recitals Books and Records Section 2.12(f)(22.17(b) Cancelled Shares Section 1.7(e) Cash Portion Section 4.2(f) CCPA Section 2.12(a)(xiv) Certificate of Incorporation Section 2.1(d) Certificate of Merger Section 1.2(a) Certificates of Merger Section 1.2(b) Charter Documents Section 2.1(d) Closing Section 1.4(a) Closing Date Section 1.4(a) Company Preamble Company Authorizations Section 2.15 Company Board Resolutions Section 2.4(a) Company Data Section 2.12(a)(ii) Company Indemnitees Section 4.5(a) Company IP Section 2.12(a)(iii) Company Owned IP Section 2.12(a)(iv) Company Prepared Returns Section 4.2(a)(i) Company Privacy Policy Section 2.12(a)(v) Company Products Section 2.12(a)(vi) Company Products Data Section 2.12(a)(vii) Company Registered IP Section 2.12(b) Company Software Section 2.12(a)(viii) Company Source Code Section 2.12(a)(ix) Company Stockholder Approval Recitals Company Voting Debt Section 2.2(f) Confidentiality Agreement Section 5.7 Contaminant Section 2.12(a)(x) Continuing Claim Section 7.4(f) Converted Option Section 1.7(b)(ii) Converted Option Exercise Price Section 1.7(b)(ii) Current Balance Sheet Section 2.7(b) D&O Indemnifiable Matters Section 4.5(a) D&O Tail Policy Section 4.5(b) Deductible Amount Section 7.3(a) Delaware LLC Act Section 1.1(b) Determination Date Section 1.15(c) DGCL Section 1.1(a) Director and Officer Resignation Letters Section 1.4(b)(iv) Disclosure Schedule Article II Dissenting Shares Section 1.11(a) Effective Time Section 1.2(a) Eligible Continuing Employee Section 5.19 Embargoed Countries Section 2.23 End Date Section 8.1(b) Engagement Letter Section 7.6(b) ePrivacy Directive Section 2.12(a)(xiv) Escrow Agreement Section 1.4(b)(xi) Escrow Fund Section 1.10(a) Estimated Closing Cash Amount Section 1.15(a) Estimated Closing Indebtedness Amount Section 1.15(a) Estimated Closing Statement Section 1.15(a) Estimated Closing Third Party Expenses Section 1.15(a) Estimated Closing Working Capital Adjustment Amount Section 1.15(a) Exchange Documents Section 1.9(b) Expense Fund Section 7.6(c) Expense Fund Account Section 7.6(c) Export Approvals Section 2.23 FCPA Section 2.24 Final Closing Statement Section 1.15(c) Financials Section 2.7(a) FIRPTA Compliance Certificate Section 1.4(b)(x) First Merger Recitals GDPR Section 2.12(a)(xiv) HSR Act Section 2.6(b) HIPAA Section 2.12(a)(xiv) Inbound Licenses Section 2.12(d)(i) Indemnification Claim Notice Section 8.3(a7.4(a) Closing Indemnification Claim Objection Notice Section 2.3 Closing Date 7.4(b) Independent Accountant Section 2.3 Company Preamble Company Common Stock 1.15(b) Intellectual Property Rights Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.12(a)(xi) Interested Party Section 2.13 Company Indemnified Parties 2.14(a) Invoice Section 8.2(a)(ii1.4(b)(vi) Contracts Lease Agreements Section 4.8(a2.11(b) Covered Party (PartiesLeased Real Property Section 2.11(b) Letter of Transmittal Section 1.9(a) Material Contract(s) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c2.13(b) Merger Section 2.1 Merger Certificate Section 2.2 Sub I Preamble Merger Sub II Preamble Merger Subs Preamble Mergers Recitals Notice of Adjustment Disagreement Section 1.15(b) Notices Section 5.11(c) OFAC Section 2.23 Open Source Material Section 2.12(a)(xii) Open Source Licenses Section 2.12(a)(xii) Outbound Licenses Section 2.12(d)(ii) Parent Preamble Parent Disclosure Schedule Article V Arrangement Section 2.9(b) Parent Certificate Section 6.3(c) Parent Financial Statements Section 3.5(b) Parent Indemnified Parties Section 8.2(a)(i7.2(a) parties Preamble Payee Parent Prepared Returns Section 8.5 Payor 4.2(a)(ii) Parent SEC Documents Section 8.5 Per Diem Taxes 3.5(a) Parent Stock Issuance Recitals Patent Rights Section 8.7(a2.12(a)(xi) Proceeding Paying Agent Agreement Section 4.17 Royalties 1.4(b)(xv) Payoff Letter Section 2.10(h1.4(b)(vi) Permitted Transferee Section 4.4(b) Personal Data Section 2.12(a)(xiii) Personnel Agreements Section 2.12(f)(i) PNO Section 2.6(b) Post-Closing Deficit Amount Section 1.15(d) Post-Closing Excess Amount Section 1.15(e) Post-Closing Statement Section 1.15(b) Privacy Requirements Section 2.12(a)(xiv) Prohibited Party Lists Section 2.23 PTO Section 2.12(b) Recovered Fraud Amounts Section 7.3(b) Registered IP Section 2.12(a)(xv) Reorg Threshold Section 4.2(f) Representative Losses Section 7.6(b) Resolved Matters Section 1.15(b) Restricted Shares Section 2.2(a) Retained Escrow Amount Section 7.4(f) Retention Pool Section 4.6 Second Certificate of Merger Section 1.2(b) Second Milestone Effective Time Section 2.10(f1.2(b) Second Milestone Payment Amount Merger Recitals Secretary Certificate Section 2.10(f1.4(b)(v) Section 280G Payments Section 5.6(b) Securityholder Representative Preamble Shrink-Wrap Software Section 2.12(a)(xvi) Standard Form Agreements Section 2.12(d)(iii) Stock Portion Section 4.2(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Notice Section 2.12(b4.1(b) Surviving Corporation Section 2.1 1.1(a) Surviving Entity Section 1.1(b) Systems Section 2.12(p) Tax Attribute Section 7.2(c) Technology Section 2.12(a)(xvii) Terminated Agreements Section 5.12 Third Milestone Party Claim Section 2.10(g7.5 Third Party Notice Section 7.5 Top Customers Section 2.25(a) Third Milestone Payment Amount Top Resellers Section 2.10(g2.25(a) Top Suppliers Section 2.25(a) Total Stockholder Consideration Section 4.2(f) Trade Laws Xxxxxxx 0.00 Xxxxxx Xxxxxx Real Property Holding Corporation Section 2.9(a)(viii) Unresolved Matters Section 1.15(b) Warrant Cancellation Agreement Section 1.4(b)(xii)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acquisition Proposal Section hereof in which such term is defined: 5.3(g)(i) Agreement Preamble Biogen Idec License Agreement Board Recitals Board Recommendation Section 4.7 Biogen Idec Supply Agreement 3.3(b) Change of Board Recommendation Section 4.7 Books and Records 5.3(a) China JV Section 2.12(f)(2) Claim Notice Section 8.3(a) 5.12 Closing Section 2.3 2.2(a) Closing Date Section 2.3 2.2(a) Closing Date Payment Section 2.2(b) Company Preamble Company Benefit Plan Section 3.14(a) Company Bylaws Section 3.1 Company Charter Section 3.1 Company Common Stock Section 2.8 3.2(a) Company Designees Section 5.18(a) Company Disclosure Schedule Article IV 3 Company Expenses Schedule Financial Statements Section 2.13 3.7(c) Company Indemnified Parties Leased Real Property Section 8.2(a)(ii3.17(a) Contracts Company Material Contract Section 4.8(a3.19 Company Meeting Section 5.4(b) Covered Party (PartiesCompany Options Section 3.2(a) Company Owned Real Property Section 8.2(a)(ii3.17(a) Damages Company Preferred Stock Section 8.2(a)(i3.2(a) Company Real Property Section 3.17(a) Company RSUs Section 3.2(a) Company SEC Documents Section 3.7(a) Company Termination Fee Section 7.3(a) Competing China JV Proposal Section 5.3(h) Confidentiality Agreement Section 5.2(b) DGCL Section 2.1 Document Retention Period 4.7 Dispute Section 2.12(f)(28.8(b) Drug Regulatory Agency ECL Claims Section 4.25 Effective Time 7.4(c) Escrow Agent Section 2.2 ERISA 5.21 Escrow Agreement Section 4.13(a5.21 FCPA Section 3.26 Guarantor Recitals Guarantee Recitals ICDR Section 8.8(b) ERISA Affiliate Intervening Event Section 4.13(a5.3(g)(v) Finally Determined Investor Preamble Investor Designees Section 8.5(b5.18(a) First Milestone Investor Sub Section 2.10(e5.22 Investor Termination Fee Release Event Section 7.4(a) First Milestone Payment Amount Letter of Credit Section 2.10(e5.23 Minority Transaction Termination Fee Section 7.3(a) Indemnifying Party OFAC Section 8.3(a3.27 Outside Date Section 7.1(d) Instrument Section 2.12(c) Merger Per Share Price Section 2.1 Merger Certificate Proposed Changed Terms Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i5.3(d)(ii) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Purchase Price Section 2.1 Third Milestone Service Provider Section 2.10(g3.14(a) Third Milestone Payment Amount Shares Section 2.10(g2.1 Superior Majority Proposal Section 5.3(g)(ii) Superior Minority Proposal Section 5.3(g)(iii) Superior Proposal Section 5.3(g)(iv)

Terms Defined Elsewhere. The following is a list of additional terms used have the meanings set forth in this Agreement and a reference to the Section hereof in which such term is definedSections set forth below: Agreement Preamble Biogen Idec License Agreement Arbitrator Section 4.7 Biogen Idec Supply Agreement 10.8(b) Available Cash Section 4.7 Books and Records 7.13 Base Premium Section 2.12(f)(27.4(d) Claim Notice Change in Recommendation Section 8.3(a6.2(d) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Board Recitals Company Group Section 2.8 9.2(d) Company Disclosure Schedule Article IV Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.2(b) Confidential Information Section 8.2(a)(ii) Contracts Section 4.8(a10.11(c) Covered Party (PartiesPersons Section 7.4(a) Deposit Agreement Section 8.2(a)(ii3.5 Depositary Section 3.5 Deposited Available Cash Section 7.13 Dissent Notice Section 3.6(b)(ii) Damages Dissent Right Section 8.2(a)(i3.6(b) DGCL Dissenting Shareholders Section 2.1 Document Retention Period 3.6(a) Dissenting Shares Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 3.6 Effective Time Section 2.2 ERISA 2.3 Enforceability Exceptions Section 4.13(a4.3 Financing Section 5.6(a) ERISA Affiliate GAAP Section 4.13(a4.6(d) Finally Determined Governmental Entity Section 8.5(b4.5 HKIAC Section 10.8(b) First Milestone HKIAC Rules Section 2.10(e10.8(b) First Milestone Payment Amount Indemnification Agreements Section 2.10(e7.4(a) Indemnifying Party Intervening Event Section 8.3(a6.2(e) Instrument Intervening Event Termination Section 2.12(c6.2(e) Limited Guarantee Recitals Loan Agreement Section 5.6(a) Material Company Permits Section 4.8 Merger Recitals Merger Consideration Section 3.2(a) Merger Consideration Fund Section 2.1 Merger Certificate Section 2.2 3.2(a) Merger Sub Preamble NASDAQ Section 4.2(b) Notice of Recommendation Change Section 6.2(d) Notice Period Section 6.2(d) Option Consideration Section 3.3(a)(i) Parent Preamble Parent Disclosure Group Section 9.2(d) Parent Termination Fee Section 9.2(c) Parties Preamble Paying Agent Section 3.2(a) Per ADS Merger Consideration Section 3.1(b) Per Share Merger Consideration Section 3.1(a) Plan of Merger Section 2.3 Record ADS Holders Section 6.3(c) Record Date Section 6.3(c) Rollover Agreement Recitals Rollover Shareholders Recitals Ruhnn1106 Section 5.6(a) Xxxxxxxx-Xxxxx Act Section 4.6(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.3(a) parties Preamble Payee SEC Documents Section 8.5 Payor 4.6(a) Securities Act Section 8.5 Per Diem Taxes 4.6(a) Share Certificates Section 8.7(a3.2(c)(i) Proceeding Special Committee Recitals Subscription Agreement Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b5.6(a) Surviving Corporation Company Section 2.1 Third Milestone Takeover Statute Section 2.10(g7.5 Transaction Litigation Section 7.8 Transactions Recitals Uncertificated Shares Section 3.2(c)(i) Third Milestone Payment Amount Vista Section 2.10(g5.6(a)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: 2004 Plan Section hereof in which such term is defined: 2.4 2009 Plan Section 2.4 Acceptance Time Section 1.1(b) Agreement Preamble Biogen Idec License Agreement Annex I Section 4.7 Biogen Idec Supply Agreement 1.1(a) ARRA Section 4.7 Books and Records 3.14(k) Balance Sheet Section 2.12(f)(23.9(b) Claim Notice Book-Entry Shares Section 8.3(a2.2(b) Breakup Fee Section 7.3(b) Certificate of Merger Section 1.5 Certificates Section 2.2(b) Change of Board Recommendation Section 5.4(b) Closing Section 2.3 1.5 Closing Date Section 2.3 1.5 COBRA Section 3.14(k) Company Preamble Company Board Recitals Company Board Recommendation Recitals Company Bylaws Section 3.2 Company Charter Section 3.2 Company Common Stock Section 2.8 Recitals Company Disclosure Schedule Preamble to Article IV III Company Expenses Schedule Representatives Section 2.13 5.3(a) Company Securities Section 3.3(a) Company Stockholder Approval Section 3.4(b) Comparable Carrier Section 5.16 Continuing Directors Section 1.3(b) DGCL Recitals Dissenting Shares Section 2.3 DOJ Section 5.8 D&O Insurance Section 5.16 Effective Time Section 1.5 Equivalent Coverage Section 5.16 ERISA Affiliate Section 3.14(a) Exchange Act Section 1.1(a) Expiration Date Section 1.1(d) Financial Advisor Section 3.22 FTC Section 5.8 Go-Shop Party Section 5.4(b) Go-Shop Period Termination Date Section 5.4(a) Holding Company Recitals Indemnification Agreements Section 5.16 Indemnified Parties Section 8.2(a)(ii5.16 Initial Expiration Date Section 1.1(d) Insurance Policies Section 3.20 Insured Persons Section 5.16 IP Contracts Section 4.8(a3.19(e) Covered Party (PartiesLeased Real Property Section 3.16(b) Material Contracts Section 8.2(a)(ii3.13(a) Damages Material Leased Real Property Section 8.2(a)(i3.16(b) DGCL Material Real Property Leases Section 2.1 Document Retention Period Section 2.12(f)(23.16(d) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Maximum Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)5.16

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: 401(k) Plan Section hereof in which such term is defined: 5.07(c) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 5.03(d)(i) Book-Entry Shares Section 4.7 Books and Records 2.02(b) Capitalization Date Section 2.12(f)(23.02(a) Claim Notice Certificate of Merger Section 8.3(a1.02 Certificates Section 2.02(b) Change of Board Recommendation Section 5.03(a)(iv) Closing Section 2.3 1.02 Closing Date Section 2.3 1.02 Company Preamble Company Common Stock Section 2.8 Board Recitals Company Board Recommendation Recitals Company Disclosure Schedule Article IV ARTICLE III Company Expenses Schedule Employees Section 2.13 5.07(a) Company Indemnified Parties Financial Statements Section 8.2(a)(ii3.07(a) Contracts Company Material Contract Section 4.8(a3.13(a) Covered Party (PartiesCompany Permits Section 3.05(a) Company Preferred Stock Section 8.2(a)(ii3.02(a) Damages Company Representatives Section 8.2(a)(i5.02(a) Company SEC Documents Section 3.06(a) Company Stockholder Approval Section 3.21 Confidentiality Agreement Section 5.02(c) D&O Insurance Section 5.08(c) DGCL Recitals Dispute Section 2.1 Document Retention Period 3.15(i) Dissenting Shares Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 2.03 Effective Time Section 2.2 ERISA 1.02 Electronic Delivery Section 4.13(a8.13 Employment Practices Section 3.12(a) ERISA Affiliate Equity Plan Documents Section 4.13(a2.04(b) Finally Determined Equity Plan Stock Section 8.5(b2.04(b) First Milestone Exon-Xxxxxx Filing Section 2.10(e5.04(c) First Milestone Payment Export Approvals Section 3.05(e) Guarantee Section 8.15(c) Guaranteed Obligations Section 8.15(a) Guarantor Section 8.15(a) Insurance Policies Section 3.17 Intervening Event Notice Period Section 5.03(e)(i) Lease Agreement Section 3.18(c) Leased Real Property Section 3.18(c) LGPL Section 3.15(f) Maximum Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c5.08(c) Merger Section 2.1 Recitals Merger Certificate Section 2.2 Consideration Recitals Merger Sub Preamble Most Recent Balance Sheet Section 3.09(a)(i) New Plans Section 5.07(a) Parent Preamble Parent Disclosure Schedule Article V 401(k) Plan Section 5.07(c) Parent Indemnified Parties Representatives Section 8.2(a)(i5.02(a) parties Preamble Payee Parent Subsidiary Section 8.5 Payor 4.03(a) Parent Welfare Plan Section 8.5 Per Diem Taxes 5.07(a) Paying Agent Section 8.7(a2.02(a) Proceeding Proxy Statement Section 4.17 Royalties 1.03(a) Xxxxxxxx-Xxxxx Act Section 2.10(h3.06(a) Second Milestone Section 2.10(f16 Section 5.10 Shares Recitals Significant Customer Section 3.23 Special Meeting Section 1.03(e) Second Milestone Payment Amount Superior Proposal Notice Period Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b5.03(d)(i) Surviving Corporation Recitals Takeover Law Section 2.1 Third Milestone 3.03(b) Termination Fee Section 2.10(g7.02(b) Third Milestone Payment Amount Unvested Cash Section 2.10(g2.04(b) WARN Act Section 3.12(e) Worker List Section 3.12(g)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Action Section hereof in which such term is defined: 4.11(b) Agreement Preamble Biogen Idec License Agreement Anglo China Preamble Anti-Corruption Laws Section 4.7 Biogen Idec Supply Agreement 4.5(b) Table of Contents Bankruptcy and Equity Exception Section 4.7 Books and Records 4.3(a) Britain Ukan Preamble Cayman Companies Law Recitals Certificates Section 2.12(f)(2) Claim Notice Section 8.3(a3.2(c) Closing Section 2.3 2.2 Closing Date Section 2.3 2.2 Company Preamble Company Common Stock Adverse Recommendation Change Section 2.8 6.4(c)(i) Company Disclosure Schedule Article IV Board Recitals Company Expenses Schedule Financial Advisors Section 2.13 4.3(b) Company Financial Statements Section 4.6(b) Company Group Section 8.2(d) Company Intellectual Property Section 4.14(b) Company Material Contract Section 4.11(a) Company Plan(s) Section 4.9(a) Company Recommendation Section 4.3(b) Company Representatives Section 6.3(a) Company SEC Filings Section 4.6(a) Company Shareholders Meeting Section 6.2(e) Company Subsidiary Section 4.1 D&O Insurance Section 6.12(b) Dissenter Rights Section 3.1(f) Dissenting Shares Section 3.1(f) Dissenting Shareholders Section 3.1(f) Effective Time Section 2.3 End Date Section 8.1(b)(i) Exchange Fund Section 3.2(a) Financing Section 5.6 Founder Vehicle Preamble HKIAC Section 9.7(c) Indemnified Parties Section 8.2(a)(ii6.12(a) Contracts Independent Committee Recitals Investments Section 4.8(a4.2(d) Covered Party (PartiesLeased Real Property Section 4.17(b) Lender Section 8.2(a)(ii) Damages 5.6 Loan Agreement Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 5.6 Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble Notice Period Section 6.4(d)(iii) Owned Real Property Section 4.17(a) Parent Preamble Table of Contents Parent Disclosure Group Section 8.2(d) Parent Representatives Section 6.3(a) Party Preamble Paying Agent Section 3.2(a) Per ADS Merger Consideration Section 3.1(b) Per Share Merger Consideration Section 3.1(b) Plan of Merger Section 2.2 Proxy Statement Section 6.2(a) Registrar of Companies Section 2.3 Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b4.4(b) Surviving Corporation Section 2.1 Third Milestone Transaction Litigation Section 2.10(g) Third Milestone Payment Amount 6.8 Uncertificated Shares Section 2.10(g3.2(c)

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section Article hereof in which such term is defined: Actual Closing Balance Sheet Section 3.4(d) Actual Closing Date Cash Section 3.4(d) Actual Closing Date Indebtedness Section 3.4(d) Actual Working Capital Section 3.4(d) Acquisition Transaction Section 7.6(a) Adjusted Merger Consideration Section 3.4(f) Agreement Preamble Biogen Idec License Agreement Assumed Option Recitals Bankruptcy and Equity Exception Section 4.7 Biogen Idec Supply Agreement 4.2 Base Balance Sheet Section 4.7 Books 4.6 Base Merger Consideration Section 3.2(a)(i) Cash, Indebtedness and Records Expenses Schedule Section 2.12(f)(23.1(h) Claim Notice Certificate of Merger Section 8.3(a) 2.2 Closing Section 2.3 Closing Date Section 2.3 Common Stock Section 3.1(b) Company Preamble Company Common Stock Dissenting Shares Section 2.8 3.5 Company Terminating Breach Section 9.1(d) Continuing Employee Section 7.14(a) Deductible Section 10.4(a) DGCL Section 2.1 Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 Employee Benefit Program Section 4.18(a) ERISA Section 4.13(a4.18(a) ERISA Affiliate Escrow Account Section 4.13(a3.3(a) Finally Determined Escrow Agent Section 8.5(b3.3(a) First Milestone Escrow Agreement Section 2.10(e3.3(a) First Milestone Payment Escrow Amount Section 2.10(e3.3(a) Estimated Closing Balance Sheet Section 3.4(a) Estimated Closing Date Cash Section 3.4(a) Estimated Closing Date Indebtedness Section 3.4(a) Estimated Working Capital Section 3.4(a) Excepted Representations Section 10.1 Final Closing Balance Sheet Section 3.4(b) Final Closing Date Cash Section 3.4(b) Final Closing Date Indebtedness Section 3.4(b) Final Working Capital Section 3.4(b) Financial Information Section 4.6 Firm Section 3.4(c) Fundamental Representations Section 10.1 HSR Act Section 4.2 Indemnified Party Section 10.3 Indemnifying Party Section 8.3(a10.3 Initial Merger Consideration Section 3.2(a) Instrument Interim Period Section 2.12(c7.1(a) Investor Restricted Period Section 7.7(b) Investor Restricted Stockholder Section 7.7(b) Losses Section 10.2 Management Restricted Period Section 7.7(b) Management Restricted Stockholder Section 7.7(b) Material Contract Section 4.13 Material Stockholder Preamble Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble Parent Preamble Parent Disclosure Net Working Capital Target Section 3.2(a)(iii) November 30, 2007 Unaudited Financials Section 4.6 Objection Notice Section 3.4(c) Other Stockholders Recitals Parachute Payment Waiver Section 7.14(e) Payment Schedule Article V Parent Indemnified Parties Section 8.2(a)(i3.1(g) parties Preamble Payee Preferred Stock Section 8.5 Payor 3.1(b) Privacy Policy Section 8.5 Per Diem Taxes 4.13(d) Released Persons Section 8.7(a7.9 Reserve Account Section 3.2(e) Proceeding Special Representations Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent 10.1 Stockholders Recitals Stockholder Stockholders’ Representative Preamble Super Majority Stockholder Indemnified Party Section 2.12(b) 10.3 Stockholder Indemnifying Party Section 10.2 Surviving Corporation Section 2.1 Third Milestone Tax Reduction Section 2.10(g7.11(b) Third Milestone Payment Amount Termination Date Section 2.10(g)9.1(f) Ticketmaster Preamble Ticketmaster Indemnified Party Section 10.2 Ticketmaster Indemnifying Party Section 10.3 Ticketmaster Plans Section 7.14(b) Ticketmaster Shares Section 6.3(a) Ticketmaster Terminating Breach Section 9.1(e) Transactions Section 2.1

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: Accounts Receivable Section 3.23(a) Additional Parent Filing Section 6.7(f) Agreement Preamble Biogen Idec License Alta Companies Interim Financial Statements Section 3.4(a) Altenative Acquisition Section 6.1(e) Alternative Financing Section 6.15(c) Antitrust Laws Section 6.2(c) Applicable Limitation Date Section 6.4(c) Bid Section 3.19(a) Binder Agreement Section 4.7 Biogen Idec Supply Agreement 6.3(a) Board Recitals Cash Consideration Section 4.7 Books and Records 1.1 Certificate of Merger Section 2.12(f)(22.1(d) Claim Notice Change in Recommendation Section 8.3(a6.7(f) Closing Section 2.3 2.1(c) Closing Date Section 2.3 2.1(c) Closing Form 8-K Section 6.7(g) Closing Press Release Section 6.7(g) Communication Policy Section 6.1(g) Company Preamble Company Common Stock Employee Benefit Plan Section 2.8 3.14(a) Company Disclosure Schedule Article IV Government Contract Section 3.19(a) Company Expenses Schedule Government Subcontract Section 2.13 3.19(a) Company Indemnified Parties Shareholder Approval Recitals Control Section 8.2(a)(ii1.1 Data Room Section 8.5 Debt Commitment Letters Section 5.6 Debt Financing Section 5.6 Definitive Debt Agreement Section 6.15(a) Contracts D&O Provisions Section 4.8(a6.11(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.1(d) Environmental Permits Section 4.13(a3.17 EquityHolder Preamble Equityholder Prepared Returns Section 6.6(a) ERISA Affiliate Excluded Shares Section 4.13(a2.2(b) Finally Determined Fee Letter Section 8.5(b5.6 Financial Statements Section 3.4(a) First Milestone Indemnified Persons Section 2.10(e6.11(a) First Milestone Payment Amount Indemnitee Section 2.10(e6.5(e) Indemnifying Party Indemnitor Section 8.3(a6.5(e) Instrument Intended Tax Treatment Recitals Interim Financial Statement Section 2.12(c3.4(a) Internal Controls Section 3.4(b) IRS Section 3.14(a) Latest Balance Sheet Section 3.4(a) LTIP Section 6.1(d) Material Customer Section 3.9(c) Material Contract Section 3.9(b) Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble NITCO Section 3.4(a) Non-Party Affiliate Section 6.14 Ordinary Course of Business Section 8.5 Outside Date Section 7.1(c) Parent Preamble Parent Disclosure Schedule Article V Prepared Returns Section 6.6(a) Parent Indemnified Parties Related party Section 8.2(a)(i7.3(b) parties Party Preamble Payee Permits Section 8.5 Payor 3.16(b) Per Share Merger Consideration Section 8.5 Per Diem 2.2(a) Pre-Closing Period Section 6.1(a) Registration Rights Agreement Section 2.4(b)(v)(I) Restrictive Covenants Section 6.16(d) R&W Deductible Section 6.3(a) R&W Insurance Company Section 6.3(a) R&W Insurance Policy Section 6.3(a) Signing Form 8-K Section 6.7(b) Signing Press Release Section 6.7(b) Stock Consdieration Section 1.1 Surviving Company Section 2.1(a) Tail Policy Section 6.11(b) Tax Contest Section 6.6(b) Third-Party Recovery Proceeds Section 6.5(d) Trade Controls Section 3.23(a) Trademarks Section 1.1 Transfer Taxes Section 8.7(a6.6(d) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)Article II TRANSACTION

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Adverse Recommendation Change Section hereof in which such term is defined: 6.02(c) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.02(c) Arbitrator Section 4.7 Books and Records 10.08(b) Assumed Option Section 2.12(f)(23.03(b) Claim Notice Base Premium Section 8.3(a7.05(d) Benefit Plan Section 4.15(b) BlueCity Holdings Limited Section 2.06 Closing Section 2.3 2.02 Closing Date Section 2.3 2.02 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Equity Interests Section 2.8 4.02(b) Company Disclosure Schedule Article IV Group Section 9.02(h) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.02(e) Competing Proposal Section 8.2(a)(ii) Contracts Section 4.8(a6.02(g) Covered Party (PartiesPersons Section 7.05(a) Deposit Agreement Section 8.2(a)(ii3.05 Depositary Section 3.05 Dissenting Shareholders Section 3.06(a) Damages Dissenting Shares Section 8.2(a)(i3.06(a) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.03 Enforceability Exceptions Section 4.03 Equity Commitment Letter Section 5.05(a) Equity Financing Section 5.05(a) Exchange Ratio Section 3.03(b) Financial Statements Section 4.06(b) HKIAC Section 10.08(b) HKIAC Rules Section 10.08(b) Indemnification Agreements Section 7.05(a) Insurance Policies Section 4.18 Intervening Event Section 6.02(e) Legal Proceeding Section 5.08 Limited Guarantee Recitals Material Contracts Section 4.16(a)(xiv) Merger Recitals Merger Consideration Section 3.02(a) Merger Consideration Fund Section 3.02(a) Merger Sub Preamble Nasdaq Section 4.02(c) Non-Required Remedy Section 7.02(d) Operating Subsidiary Section 4.16(a)(xi) Parent Preamble Parent Group Section 9.02(h) Parent Termination Fee Section 9.02(f) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Per ADS Merger Consideration Section 3.01(b) Per Share Merger Consideration Section 3.01(a) Plan of Merger Section 2.03 PRC Subsidiaries Section 4.09(a) Proxy Statement Section 4.05 Record ADS Holders Section 6.04(a) Record Date Section 6.04(a) Registrar of Companies Section 2.03 Rollover Shareholders Recitals Sxxxxxxx-Xxxxx Act Section 4.06(a) Schedule 13E-3 Section 6.03(a) SEC Documents Section 4.06(a) Securities Act Section 4.06(a) Share Certificates Section 3.02(b)(i) Social Insurance Section 4.15(k) Special Committee Recitals Superior Proposal Section 6.02(h) Support Agreement Recitals Surviving Company Section 2.01 Takeover Statute Section 4.23 Tax Returns Section 4.13(a) ERISA Affiliate Transaction Litigation Section 4.13(a7.08 Transactions Recitals U.S. GAAP Section 4.06(b) Finally Determined Uncertificated Shares Section 8.5(b3.02(b)(i) First Milestone VIE Contracts Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g4.09(c)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: 2.01(e) Agreement Preamble Biogen Idec License Agreement Alternative Financing Section 4.7 Biogen Idec Supply Agreement 8.09(b) Alternative Financing Documents Section 4.7 Books and Records 8.09(b) Arbitrator Section 2.12(f)(211.08(b) Claim Notice Base Premium Section 8.3(a8.04(d) Change in the Company Recommendation Section 7.02(b) Closing Section 2.3 3.02 Closing Date Section 2.3 3.02 Company Preamble Company Common Stock Board Recitals Company Board Actions Recitals Company Board Recommendation Recitals Company Equity Interests Section 2.8 5.02(a) Company Disclosure Schedule Article IV Group Section 10.02(d) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 10.02(b) Competing Proposal Section 8.2(a)(ii7.02(d) Contracts Competition Laws Section 4.8(a5.05 Covered Persons Section 8.04(a) Covered Party (PartiesDebt Commitment Letter Section 6.05(a) Debt Financing Source Section 8.2(a)(ii6.05(a) Damages Deposit Agreement Section 8.2(a)(i) DGCL 4.05 Depositary Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 4.05 Effective Time Section 2.2 ERISA 3.03 Enforceability Exceptions Section 4.13(a5.03(a) ERISA Affiliate Expiration Time Section 4.13(a2.01(c)(ii)(B) Finally Determined Financing Section 8.5(b6.05(a) First Milestone Financing Condition Annex A Financing Document Section 2.10(e8.09(b) First Milestone Payment Amount GAAP Section 2.10(e5.06(b) Indemnifying Party Governmental Entity Section 8.3(a5.05 HKIAC Section 11.08(b) Instrument HKIAC Rules Section 2.12(c11.08(b) Indemnification Agreements Section 8.04(a) Intervening Event Section 7.02(g) Intervening Event Termination Section 7.02(g) Legal Proceeding Section 6.06 Xxx Preamble Merger Recitals Merger Consideration Section 2.1 Merger Certificate 4.02(a) Minimum Condition Annex A Non-Required Remedy Section 2.2 Merger Sub Preamble 8.02(e) Offer Recitals Offer Conditions 2.01(a) Offer Documents Section 2.01(f) Offer Price Recitals Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Termination Fee Section 10.02(c) Parties Preamble Party Preamble Paying Agent Section 8.2(a)(i4.02(a) parties Preamble Payee Payment Fund Section 8.5 Payor 4.02(a) Per ADS Merger Consideration Section 8.5 4.01(b) Per Diem Taxes Share Merger Consideration Section 8.7(a4.01(a) Proceeding Plan of Merger Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment 3.03 Required Amount Section 2.10(f6.05(c) Stockholder Consent Xxxxxxxx-Xxxxx Act Section 5.06(a) Schedule TO Section 2.01(f) Schedule 13E-3 Section 2.02(b) Schedule 14D-9 Section 2.02(b) SEC Documents Section 5.06(a) Securities Act Section 5.06(a) Share Certificates Section 4.02(b)(i) Special Committee Recitals Stockholder Representative Special Committee Recommendation Recitals Super ROI Preamble Super Majority ROI Group Section 2.12(b10.02(d) Superior Proposal Section 7.02(f) Surviving Corporation Company Section 2.1 Third Milestone 3.01 Takeover Statute Section 2.10(g) Third Milestone Payment Amount 8.05 Transaction Litigation Section 2.10(g8.07 Transactions Recitals Uncertificated Shares Section 4.02(b)(i)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement Agreement, as indicated below: Acquired Companies Acquired Company Interests Acquired Entity Deferred Compensation Plans Antitrust Division Recitals Recitals Section 5.2(g)(ii) Section 5.5(b) -22- Applicable Severance Plan Approval Section 5.2(c)(i) Section 5.7(c) Asset Basis Section 5.16(g)(i) Bankruptcy and a reference to the Equity Principles Section hereof in which such term is defined: Agreement 3.2 Basis Information Section 5.16(g)(i) Business CBA Section 3.19(a) Business Environmental Reports Section 5.25 Business Reports Section 3.11 Buyer Preamble Biogen Idec License Buyer 401(k) Plan Section 5.2(f)(i) Buyer Controlled Action Section 5.19(a) Buyer Deferred Compensation Plans Section 5.2(g)(i) Buyer Employee DCP Participants Section 5.2(g)(i) Buyer Indemnified Parties Section 8.2 Buyer Parent Recitals Buyer Parent Guarantee Recitals Buyer’s Allocation Section 5.16(a)(i) Cap Section 8.5(a)(i) Casualty Event Section 2.5(b) Casualty Event Notice Section 2.5(b) Casualty Loss Adjustment Site Section 2.5(c) Chosen Courts Section 9.1 claim Section 1.1 Claim Notice Section 8.4(b) Closing Section 2.3(a) Closing Cash Amounts Section 2.4(b) Closing Date Section 2.3(a) Closing Indebtedness Section 2.4(b) Closing Month Section 1.1 Closing Net Working Capital Section 2.4(b) Closing Section 338(h)(10) Election Amount Section 2.4(b) Collective Bargaining Agreement Section 4.7 Biogen Idec 3.19(a) Competing Business Section 5.26(b)(ii) Condemnation Action Section 5.28(a) Confidential Business Information Section 5.4(b) Continuation Period Section 5.2(c)(i) Corporate Policies Section 5.13 Covered Parties Section 5.17 COVID-19 Conditions Section 1.1 Current Representation Section 9.17(a) Cutoff Date Section 8.1(a) Damaged Retail Site Section 2.5(b) debt Section 1.1 Debt Financing Section 5.27(a) Deemed Section 338(h)(10) Election Transactions Section 5.16(e) Designated Person -23- Section 9.17(a) Disagreement Notice Section 2.4(c) Disclosing Party Section 5.4(c) Disputed Item Section 2.4(c) Divestiture Actions Section 5.5(c) Divestiture Event Section 5.26(d) DOL Section 3.21(c) Effective Time Section 2.3(a) Estimated Closing Cash Amounts Section 2.4(a)(i) Estimated Closing Indebtedness Section 2.4(a)(i) Estimated Net Working Capital Section 2.4(a)(i) Excluded Businesses Section 1.1 Excluded Marks Section 5.14(a) Excluded Retail Operations Section 5.26(b)(iv) Expenses Schedule Section 9.4(b) Final Allocation Section 5.16(a)(i) Final Cash Amounts Section 2.4(h) Final Closing Adjustment Section 2.4(j) Final Indebtedness Section 2.4(h) Final Net Working Capital Section 2.4(h) Final Purchase Price Section 2.4(j) Final Section 338(h)(10) Election Amount Section 2.4(h) FLSA Section 3.19(b) FTC Section 5.5(b) Governmental Filings Section 3.4 Grandfathered Participants Section 5.2(f)(ii) Incremental Fuel Supply Agreement Section 4.7 Books and Records 5.30(b) Indemnified Party Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e8.4(a) Indemnifying Party Section 8.3(a8.4(a) Instrument Independent Accounting Firm Section 2.12(c2.4(e) Merger Initial Purchase Price Section 2.4(a)(ii) Interim Financial Statements Section 5.22(a) IRS Section 3.21(b) Like-Kind Exchange Section 5.16(l) Losses Section 8.2 Marketing Materials Section 5.27(a) Material Contract Section 3.18(a) Monetization Transaction Section 5.27(d) New Price Section 5.26(d) New Seller Deferred Compensation Plans Section 5.2(g)(ii) Non-Business Employee DCP Participants Section 5.2(g)(ii) Notice Period Section 8.4(b) Offer Notice Section 5.26(d) Offer Price Section 5.26(d) Outside Date Section 7.1(b) Partial Condemnation Actions Section 5.28(a) PBGC -24- Section 3.21(d) Permits Section 3.20(b) Post-Closing Representation Section 9.17(a) Pre-Closing Separate Tax Return Section 5.16(i)(i) Preliminary Adjustment Statement Section 2.4(b) Privileged Communications Section 9.17(b) R&W Insurance Policy Section 5.24 Resolution Period Section 2.4(e) Restricted Activities Section 5.26(a) Restricted Area Section 5.26(a) Restricted Parties Section 5.26(a) Retained Deferred Compensation Plans Section 5.2(g)(iii) Review Period Section 2.4(c) ROFO Section 5.26(d) ROFO Event Section 5.26(d) ROFO Notice Section 5.26(d) RSSP Section 5.2(f)(i) Sale Section 2.1 Merger Certificate Sale Notice Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent 5.26(d) Section 338(h)(10) Election Section 5.16(g)(i) Section 338(h)(10) Election Accounting Firm Section 5.16(g)(i) Section 338(h)(10) Election Amount Section 5.16(g)(i) Section 338(h)(10) Forms Section 5.16(g)(iii) Seller Controlled Action Section 5.19(a) Seller Deferred Compensation Plans Section 5.2(g)(i) Seller Guarantors Section 5.20(a) Seller Indemnified Parties Section 8.2(a)(i8.3 Seller Parent Preamble Seller Surviving Representations Section 8.1(a) parties Seller Thrift Plan Section 5.2(f)(i) Sellers Preamble Payee Separation Activities Section 8.5 Payor 5.7(a) Separation Plan Section 8.5 Per Diem Taxes 5.7(a) Service Credits Section 8.7(a5.2(c)(ii) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Signing Date Preamble Speedway Retirement Plan Sharing Amount Section 2.10(f5.2(e) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Stock Basis Section 2.12(b5.16(g)(i) Surviving Corporation Stock Purchase Subsidiaries Section 2.1 Third Milestone 5.16(g)(i) Straddle Period Section 2.10(g5.16(h)(i) Support Services Section 5.12 Tax Claim Section 5.16(k)(i) Tax Clearance Certificates Section 5.16(m) Terminating Contracts Section 5.11(a) Third Milestone Payment Amount Party Claim Section 2.10(g)8.4(b) Threshold Section 8.5(a)(i) Total Condemnation Actions Section 5.28(b) Transaction Accounting Principles -25- Section 1.1 Transferred Employees Transition Services Agreement Transportation Services Agreements Unclaimed Property Reports Section 5.2(a)(iii) Section 5.30(a) Section 5.30(c) Section 3.31 Union Section 3.19(a) Unresolved Items Section 2.4(f) willful and material breach -26- Section 7.2

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: 2.4(a) Action Section 5.14 Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 7.5(c)(ii) Articles of Merger Section 4.7 Books and Records 3.3 Bankruptcy Exception Section 2.12(f)(25.12(b) Claim Notice Board Appointment Date Section 8.3(a2.4(a) Certificates Section 4.2(b) Closing Section 2.3 3.2 Closing Date Section 2.3 3.2 COI Section 5.13(a)(vi) Company Preamble Company Adverse Recommendation Change Section 7.5(c)(i) Company Board Recommendation Section 2.3(a)(iv) Company Common Stock Recitals Company Disclosing Party Section 2.8 1.1(cc) Company Disclosure Schedule Article IV Documents Section 7.20(a) Company Expenses Schedule Financial Advisor Section 2.13 5.3(c) Company Indemnified Parties Financial Statements Section 8.2(a)(ii5.6(b) Contracts Company Intellectual Property Section 4.8(a5.16(b) Covered Party (PartiesCompany Material Contract Section 5.12(a) Company Plan(s) Section 8.2(a)(ii5.10(a) Damages Company Preferred Stock Section 8.2(a)(i5.2(a) DGCL Company Representatives Section 2.1 Document Retention Period 7.4(a) Company SEC Filings Section 2.12(f)(25.6(a) Drug Regulatory Agency Company Stockholder Approval Section 4.25 5.3(b) Company Stockholders’ Meeting Section 7.2(a) Company Subsidiary Section 5.1 Compensation Committee Section 5.25 Continuing Directors Section 2.4(a) Effective Time Section 2.2 3.3 Employment Compensation Arrangement Section 5.25 End Date Section 9.1(b) ERISA Section 4.13(a5.10(a) ERISA Affiliate Section 4.13(a5.10(a) Finally Determined Exchange Fund Section 8.5(b4.2(a) First Milestone Indemnified Parties Section 2.10(e7.12(a) First Milestone Payment Amount Independent Directors Section 2.10(e2.4(b) Indemnifying Party Investments Section 8.3(a5.2(d) Instrument IRS Section 2.12(c5.10(b) JV Partner Section 1.1(o) Merger Recitals Merger Consideration Section 2.1 Merger Certificate Section 2.2 4.1(a) Merger Sub Preamble Minimum Condition Section 2.1(b) Notice Period Section 7.5(d)(iii) Offer Recitals Offer Documents Section 2.1(g) Offer Price Recitals Parent Preamble Parent Disclosure Expenses Section 9.4(c) Parent Plans Section 7.18(a) Parent Representatives Section 7.4(a) Party Preamble Paying Agent Section 4.2(a) Proxy Statement Section 7.2(b) Purchaser Welfare Benefit Plans Section 7.18(c) Reimbursable Expenses Section 9.4(c) SCC Section 3.3 Schedule Article V Parent Indemnified Parties TO Section 8.2(a)(i2.1(g) parties Preamble Payee Schedule 14D-9 Section 8.5 Payor 2.3(b) Software Section 8.5 Per Diem Taxes Section 8.7(a1.1(kk) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Support Agreement Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone 3.1 Tail Period Section 2.10(g7.12(c) Third Milestone Payment Amount Takeover Provisions Section 2.10(g2.3(a)(iii) Top-Up Option Section 2.2(a) Top-Up Option Shares Section 2.2(d) VSCA Section 2.2(a)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: $ Section hereof in which such term is defined: 1.3(c) Adverse Recommendation Change Section 6.2(c) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.2(c) Arbitrator Section 4.7 Books and Records 10.8(b) Base Premium Section 2.12(f)(27.4(d) Claim Notice CICL Section 8.3(a) 2.1 Closing Section 2.3 2.2 Closing Date Section 2.3 2.2 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Equity Interests Section 2.8 4.2(a) Company Disclosure Schedule Article IV Group Section 9.2(h) Company Expenses Schedule Intellectual Property Rights Section 2.13 4.11(a) Company Indemnified Parties Termination Fee Section 8.2(a)(ii9.2(e) Contracts Competing Proposal Section 4.8(a6.2(g) Covered Party (PartiesPersons Section 7.4(a) Dissenting Shareholders Section 8.2(a)(ii3.3(a) Damages Dissenting Shares Section 8.2(a)(i3.3(a) DGCL Dollars Section 2.1 Document Retention Period Section 2.12(f)(21.3(c) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.3 Enforceability Exceptions Section 4.13(a4.3 Equity Commitment Letter Section 5.5(a) ERISA Affiliate Equity Financing Section 4.13(a5.5(a) Finally Determined Exchange Act Section 8.5(b4.5 Exchange Fund Section 3.2(a) First Milestone Financial Statements Section 2.10(e4.6(b) First Milestone Payment Amount Fuling Global, Inc. Section 2.10(e2.6 GAAP Section 4.6(b) Indemnifying Party Governmental Entity Section 8.3(a4.5 HKIAC Section 10.8(b) Instrument Indemnification Agreements Section 2.12(c7.4(a) Legal Proceeding Section 4.12 Merger Recitals Merger Consideration Section 2.1 Merger Certificate Section 2.2 3.2(a) Merger Sub Preamble Nasdaq Section 4.5 Non-Required Remedy Section 7.2(e) Parent Preamble Parent Disclosure Group Section 9.2(h) Parent Termination Fee Section 9.2(f) Parties Preamble Party Preamble Paying Agent Section 3.2(a) Per Share Merger Consideration Section 3.1(a) Plan of Merger Section 2.3 Proxy Statement Section 4.5 Record Date Section 6.4(a) Regulatory Filings Section 4.5 Rollover Shareholders Recitals Rules Section 10.8(b) Xxxxxxxx-Xxxxx Act Section 4.6(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.3(a) parties Preamble Payee SEC Section 8.5 Payor 4.5 SEC Documents Section 8.5 Per Diem Taxes 4.6(a) Securities Act Section 8.7(a4.8 Share Certificates Section 3.2(b)(i) Proceeding Special Committee Recitals Superior Proposal Section 4.17 Royalties Section 2.10(h6.2(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Support Agreements Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Entity Section 2.1 Third Milestone Takeover Statute Section 2.10(g) Third Milestone Payment Amount 4.16 Transaction Litigation Section 2.10(g7.7 Transactions Recitals Uncertificated Shares Section 3.2(b)(i)

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Aggregate Outstanding Claims Section 2.9(b) Agreement Preamble Biogen Idec License Agreement Basket Amount Section 4.7 Biogen Idec Supply Agreement 8.5(a) Benefit Plan(s) Section 4.7 Books and Records 4.14(a) CERCLA Section 2.12(f)(2) 4.13 Claim Notice Section 8.3(a) Closing Section 2.3 Closing Amount Section 2.10(a) Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 2.8(a) Company Preamble Company Disclosure Schedule Article IV Company Expenses Schedule Dissenting Shares Section 2.13 2.11 Company Indemnified Parties Partner Section 8.2(a)(ii) Contracts Section 4.8(a) 4.27 Covered Party (Parties) Section 8.2(a)(ii8.2(a) Damages Section 8.2(a)(i8.2(a) DGCL Section 2.1 Document Retention Period Dispute Notice Section 2.12(f)(22.13(h) Drug Regulatory Agency Section 4.25 4.27 Effective Time Section 2.2 Employee Loans Section 4.8(a) Environmental Laws Section 4.13 Equityholder Representative Preamble ERISA Section 4.13(a4.14(a) ERISA Affiliate Section 4.13(a4.14(a) Finally Determined Escrow Account Section 8.5(b2.9(a) Escrow Agent Section 2.9(a) Escrow Agreement Section 2.9(a) Escrow Amount Section 2.9(a) Escrow Earnings Section 2.9(c) First Milestone Section 2.10(e) First Milestone MAA Subsequent Payment Amount Section 2.10(e) Indemnifying Party First NDA Subsequent Payment Amount Section 8.3(a2.10(f) Hazardous Materials Section 4.13 HSR Act Section 4.17 Instrument Section 2.12(c2.13(c) IRS Section 4.14(d) Majority Section 2.13(b) Material Contracts Section 4.8(a) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Net Cash Section 4.10(b) Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Parent-Prepared Tax Return Section 8.2(a)(i6.2(a) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Preferred Stock Section 2.8(a) Proceeding Section 4.17 Royalties 4.18 Real Property Section 4.5(c) Required Company Stockholder Vote Section 4.3 Retained Escrow Amount Section 2.9(b) Rules Section 4.28 Second MAA Subsequent Payment Amount Section 2.10(g) Second NDA Subsequent Payment Amount Section 2.10(h) Second Milestone Series A Preferred Stock Section 2.10(f2.8(a) Second Milestone Payment Amount Section 2.10(fStockholder(s) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Tax Consent Section 2.10(g6.2(c) Third Milestone Payment Amount Transaction Fee Schedule Section 2.10(g)2.14

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms used have the meanings set forth in this Agreement and a reference to the Sections indicated: Term Section hereof in which such term is defined: 2017 Financial Statements Section 5.13(a) Acquisition Transaction Section 5.9 Agreement Preamble Biogen Idec License Agreement Agreements and Instruments Section 4.7 Biogen Idec Supply Agreement 4.12 Allocation Statement Section 4.7 Books and Records 2.7(a) Annual Financial Statements Section 2.12(f)(23.6 Antitrust Laws Section 5.4(b) Claim Notice Balance Sheet Section 8.3(a3.6 Balance Sheet Date Section 3.6 Basket Section 8.5(a) Cash Consideration Amount Section 2.2(a) Closing Section 7.4 Closing Cash Consideration Section 2.3 Closing Date Section 7.4 Closing Net Working Capital Section 2.4(a) Closing Statement Section 2.4(a) Company Released Parties Section 5.10(a) Cumulative Revenue Make Up Amount Section 2.5(a) Dispute Notice Section 2.4(b) Disputed Amount Section 2.6(b) Earnout Recipients Section 2.5(d) Earnout Statement Section 2.5 Employee Benefit Plans Section 3.14(a) Equity Interests Recitals Estimated Closing Statement Section 2.3 Company Estimated Net Working Capital Section 2.3 FCPA Section 3.17(c) Financial Statements Section 3.6 Fraud Claims Section 8.1(b) X. Xxxxxx Guaranties Section 5.14 HSR Act Section 3.5(b) Indemnification Claim Section 8.4(a) Indemnity Cap Section 8.5(d) Insurance Policies Section 3.21 Interim Financial Statements Section 3.6 Leased Real Property Section 3.10(a) Losses Section 8.2(a) Material Contracts Section 3.13(a) Material Customers Section 3.24(a) Material Vendors Section 3.24(a) Non-Disclosure Agreement Section 5.6(a) NYSE Section 4.13 Objection Notice Section 2.5(c) Party and Parties Preamble Company Payoff Letters Section 7.1(i) Personal Property Leases Section 3.11 Purchaser Preamble Purchaser Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.2(a) Purchaser Documents Section 2.13 Company 4.2 Purchaser Financial Statements Section 4.10 Purchaser Indemnified Parties Section 8.2(a)(ii8.2(a) Contracts Purchaser Plans Section 4.8(a6.1(b) Covered Party (PartiesPurchaser Preferred Stock Section 4.9(a) Purchaser SEC Documents Section 8.2(a)(ii4.11(a) Damages R&W Policy Premium Section 8.2(a)(i8.10 Real Property Leases Section 3.10(a) DGCL 93 Required Quarter Financial Statements Section 2.1 Document Retention Period 5.13(a) Rights-of-Way Section 2.12(f)(23.10(a) Drug Regulatory Agency SEC Section 4.25 Effective Time 4.10 Seller Documents Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent 3.2 Seller Indemnified Parties Section 8.2(a)(i8.3 Sellers Representative Section 9.1(a) parties Sellers Preamble Payee Specified Creditors Section 8.5 Payor 2.3(b) Specified Indebtedness Section 8.5 Per Diem Taxes 2.3(b) Specified Indebtedness Statement Section 8.7(a2.3(b) Proceeding Tax Matter Section 4.17 Royalties 9.2(d) Termination Date Section 2.10(h7.5(a) Second Milestone Transaction Consideration Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)2.2

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Acquisition Sub Preamble Aggregate Loss Threshold Section 8.3(a) Agreement Preamble Biogen Idec License Agreement Available NOL Amount Section 4.7 Biogen Idec Supply Agreement 2.15(c) CIC Amendment Section 4.7 Books and Records Section 2.12(f)(25.14(b) Claim Notice Section 8.3(a8.4(a) Closing Section 2.3 2.3(a) Closing Date Section 2.3 2.3(a) Closing Working Capital Section 2.13(a)(i) Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV III Company Expenses Schedule Intellectual Property Section 2.13 Company Indemnified Parties 3.17(a) Credits Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii2.15(a) Damages Section 8.2(a)(i8.2(a), (c) Decline Date Section 2.13(d) DGCL Section 2.1 Document Retention Period Dispute Notice Section 2.12(f)(28.4(b) Drug Regulatory Agency Disputed Line Items Section 4.25 2.13(d) Dissenting Shares Section 2.16(a) Dissenting Shares Reduction Amount Section 2.16(b) Effective Time Section 2.2 ERISA Equityholder Indemnified Parties Section 4.13(a8.2(b) ERISA Affiliate Estimated Working Capital Section 4.13(a2.13(b) Finally Determined Estimated Working Capital Adjustment Section 8.5(b2.13(b) First Milestone Final Working Capital Adjustment Section 2.10(e2.13(e) First Milestone Payment Amount Form Working Capital Statement Section 2.10(e2.13(a)(i) Indemnifying General Survival Date Section 8.1 Hireworks Section 5.15 Indemnified Officers Section 5.10 Indemnified Party Section 8.3(a8.4(a) Instrument Indemnitor Section 2.12(c8.4(b) Initial Calculation Section 2.13(c) Kenexa Indemnified Parties Section 8.2(a) Kenexa Technology Preamble Labor Union Section 3.16(a)(i) Letter of Transmittal Section 2.10(b) Material Contracts Section 3.6(a) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Net Adjustment Amount Section 2.13(f) NOL Adjustment Amount Section 2.15(c) NOL Study Section 2.15(b) NOLs Section 2.15(a) Notice of Disagreement Section 2.13(d) Notice of NOL Disagreement Section 2.15(c) Option Cancellation Agreement Section 2.11 Option Holder Section 3.4(c) Outside Date Section 7.1(b) Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Pre-Closing Taxes Section 5.11(a) Relevant Group Section 3.10(a)(i) Representative Preamble Representative Agreement Section 8.8(a) Representative Parties Section 8.2(a)(i8.8(f)(iii) parties Preamble Payee Settlement Accountants Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f2.13(d) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Approval Section 2.12(b3.3(b) Straddle Period Section 5.11(a) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Targeted Credit Amount Section 2.10(g2.15(a) Targeted NOL Amount Section 2.15(a) Tax or Taxes Section 3.10(a)(ii) Tax Return Section 3.10(a)(iii) Terminated Plan Section 3.16(b)(i) Transaction Expense Statement Section 2.9(a) Transfer Taxes Section 3.10(a)(iv)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Action Section hereof in which such term is defined: 4.09 Agreement Preamble Biogen Idec License Agreement Arbitrator Section 4.7 Biogen Idec Supply Agreement 10.08(b) Base Premium Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a7.04(d) Closing Section 2.3 2.02 Closing Date Section 2.3 2.02 Company Preamble Company Common Stock Board Recitals Company Equity Interests Section 2.8 4.02(a) Company Disclosure Schedule Article IV Group Section 9.02(d) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.02(b) Competing Proposal Section 8.2(a)(ii) Contracts Section 4.8(a6.02(d) Covered Party (PartiesPersons Section 7.04(a) Deposit Agreement Section 8.2(a)(ii3.05 Depositary Section 3.05 Dissent Notice Section 3.06(d) Damages Dissent Right Section 8.2(a)(i3.06(d) DGCL Dissenting Shareholders Section 2.1 Document Retention Period 3.06(a) Dissenting Shares Section 2.12(f)(23.06(a) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.03 Enforceability Exceptions Section 4.13(a4.03 Equity Commitment Letter Section 5.05(a) ERISA Affiliate Equity Commitment Letters Section 4.13(a5.05(a) Finally Determined Equity Financing Section 8.5(b5.05(a) First Milestone GAAP Section 2.10(e4.06(b) First Milestone Payment Amount Governmental Entity Section 2.10(e4.05 HKIAC Section 10.08(b) Indemnifying Party HKIAC Rules Section 8.3(a10.08(b) Instrument Indemnification Agreements Section 2.12(c7.04(a) Intervening Event Section 6.02(h) Intervening Event Termination Section 6.02(h) Legal Proceeding Section 5.06 Limited Guarantee Recitals Merger Recitals Merger Consideration Section 3.02(a) Merger Consideration Fund Section 2.1 Merger Certificate Section 2.2 3.02(a) Merger Sub Preamble Non-Required Remedy Section 7.02(d) NYSE Section 4.02(a) OTC Market Section 4.02(a) Parent Preamble Parent Disclosure Group Section 9.02(d) Parent Termination Fee Section 9.02(c) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Per ADS Merger Consideration Section 3.01(b) Per Share Merger Consideration Section 3.01(a) Plan of Merger Section 2.03 Record ADS Holders Section 6.03(c) Record Date Section 6.03(c) Rollover Agreements Recitals Rollover Shareholders Recitals Xxxxxxxx-Xxxxx Act Section 4.06(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.03(a) parties Preamble Payee SEC Documents Section 8.5 Payor 4.06(a) Securities Act Section 8.5 Per Diem Taxes 4.06(a) Share Certificates Section 8.7(a3.02(b)(i) Proceeding Special Committee Recitals Superior Proposal Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b6.02(f) Surviving Corporation Company Section 2.1 Third Milestone 2.01 Takeover Statute Section 2.10(g) Third Milestone Payment Amount 7.05 Transaction Litigation Section 2.10(g7.07 Transactions Recitals Uncertificated Shares Section 3.02(b)(i)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Section hereof in which such term is definedAgreement, as indicated below: Action ‎Section 4.14(a) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2‎Section 6.4(c)(ii) Claim Notice Section 8.3(aArticles of Merger ‎Section 2.3 Bankruptcy Exception ‎Section 4.3(a) Certificates ‎Section 3.2(b) Closing Section 2.3 ‎Section 2.2 Closing Date Section 2.3 ‎Section 2.2 Company Preamble Company Common Stock Section 2.8 Adverse Recommendation Change ‎Section 6.4(c)(i) Company Board Recommendation ‎Section 4.3(d) Company Disclosure Schedule Article IV Documents ‎Section 4.10(a) Company Expenses Schedule Section 2.13 Financial Advisor ‎Section 4.3(c) Company Indemnified Parties Section 8.2(a)(iiFinancial Statements ‎Section 4.7(b) Contracts Section 4.8(aCompany Intellectual Property ‎Section 4.16(a) Covered Party (PartiesCompany Material Contract ‎Section 4.13(a) Section 8.2(a)(iiCompany Plan(s) Damages Section 8.2(a)(i‎Section 4.11(a) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2Company Preferred Stock ‎Section 4.2(a) Drug Regulatory Agency Section 4.25 Company Representatives ‎Section 6.3(a) Company SEC Filings ‎Section 4.7(a) Company Shareholder Approval ‎Section 4.3(b) Company Shareholders Recitals Company Shareholders’ Meeting ‎Section 6.2(c) Company Subsidiary ‎Section 4.1 Determination Notice ‎Section 6.4(d)(i)(C) Effective Time Section 2.2 ‎Section 2.3 End Date ‎Section 8.1(b)(i) ERISA Section 4.13(a‎Section 4.11(a) ERISA Affiliate Section 4.13(a‎Section 4.11(a) Finally Determined Section 8.5(bExchange Fund ‎Section 3.2(a) First Milestone Section 2.10(eImprovements ‎Section 4.19(c) First Milestone Payment Amount Section 2.10(eIndemnified Parties ‎Section 6.11(a) Indemnifying Party Section 8.3(aIntervening Event Change of Recommendation ‎Section 6.4(d)(ii) Instrument Section 2.12(cInvestments ‎Section 4.2(d) IRS ‎Section 4.11(b) Measurement Date ‎Section 4.2(a) Merger Section 2.1 Recitals Merger Certificate Section 2.2 Consideration ‎Section 3.1(a) Merger Sub Preamble Multiemployer Plan ‎Section 4.11(c) Notice Period ‎Section 6.4(d)(i)(C) OFAC ‎Section 1.1(v) Parent Preamble Parent Disclosure Schedule Article V Expenses ‎Section 8.2(c) Parent Indemnified Parties Section 8.2(a)(iRepresentatives ‎Section 6.3(a) parties Party Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(aPaying Agent ‎Section 3.2(a) Proceeding Section 4.17 Royalties Section 2.10(hPerformance Awards ‎Section 3.5(d) Second Milestone Section 2.10(fProxy Statement ‎Section 6.2(a) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(bRecent SEC Reports ‎Article IV Rollover Option ‎Section 3.5(b) Surviving Corporation Section ‎Section 2.1 Third Milestone Section 2.10(gTail Period ‎Section 6.11(c) Third Milestone Payment Amount Section 2.10(g)Takeover Provisions ‎Section 4.21(a) TBCA Recitals Transaction Litigation ‎Section 6.6 WARN Act ‎Section 4.12

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Acquisition Proposal Section 5.04(a) Agreement Preamble Biogen Idec License Agreement Audited Financial Statements Section 4.7 Biogen Idec Supply Agreement 3.06 Articles of Merger Section 4.7 Books and Records 2.05 Balance Sheet Section 2.12(f)(23.06 Balance Sheet Date Section 3.06 Basket Section 8.04(a) Claim Notice Benefit Plan Section 8.3(a3.18(a) Cap Section 8.04(a) Closing Section 2.3 2.03 Closing Date Section 2.3 2.03 Closing Statement Section 2.02 Common Stock Section 3.04(a) Company Preamble Company Common Stock Board Recitals Company Board Recommendation Section 2.8 3.02(b) Company Disclosure Schedule Article IV Charter Documents Section 3.01(a) Company Expenses Schedule Counsel Section 2.13 10.14(a) Company Special Meeting Section 5.05 Company Subsidiary Charter Documents Section 3.01(b) Confidentiality Agreement Section 5.03(c) Continuing Employees Section 5.12(a) Direct Claim Section 8.05(c) Disputed Amounts Section 2.16(b)(iii) Dissenting Shares Section 2.10 D&O Indemnified Parties Party Section 8.2(a)(ii5.11(a) Contracts D&O Tail Policy Section 4.8(a5.11(b) Covered Party (PartiesEarn-out Calculation Section 2.17(b)(i) Earn-out Calculation Objection Notice Section 8.2(a)(ii2.17(b)(iii) Damages Earn-out Calculation Statement Section 8.2(a)(i2.17(b)(i) DGCL Section 2.1 Document Retention Earn-out Review Period Section 2.12(f)(22.17(b)(ii) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.05 End Date Section 4.13(a9.01 Escrow Funds Section 2.12(b) ERISA Affiliate Excess Working Capital Section 4.13(a2.16(c)(ii) Finally Determined Financial Statements Section 8.5(b3.06 FIRPTA Statement Section 6.07 Government Contracts Section 3.09(a)(v) First Milestone Indemnification Escrow Fund Section 2.10(e2.12(a)(i) First Milestone Payment Amount Independent Accountant Section 2.10(e2.16(b)(iii) Indemnifying Party Insurance Policies Section 8.3(a3.14 Interim Balance Sheet Section 3.06 Interim Balance Sheet Date Section 3.06 Interim Financial Statements Section 3.06 iSun Residential Preamble iSun Residential Board Recitals Letter of Transmittal Section 2.11(c) Instrument Liabilities Section 2.12(c3.07 Lockup Period Section 5.15 Majority Holders Section 10.01(e) Material Contracts Section 3.09(a) Material Customers Section 3.13(a) Material Suppliers Section 3.13(b) Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble Merger Sub Board Recitals Parent Preamble Parent Disclosure Schedule Article V Board Recitals Parent Indemnified Equity Awards Section 4.11(b)(i) Parent Indemnitees Section 8.02 Parent Preferred Stock Section 4.11(a) Parent Restricted Share Section 4.11(b)(i) Parent SEC Documents Section 4.01 Parent Securities Section 4.11(b)(ii) Parent Stock Plans Section 4.11(b)(i) Parent Stock Option Section 4.11(b)(i) Parent Subsidiaries Preamble Parent Subsidiary Securities Section 4.11(d) Parent Voting Debt Section 4.11(c) Party Preamble Parties Preamble Permitted Encumbrances Section 8.2(a)(i3.10(a) parties Preamble Payee Post-Closing Adjustment Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a2.16(c) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority PPP Escrow Fund Section 2.12(b) Preferred Stock Section 3.04(a) Privileged Communications Section 10.14(d) Registrable Shares Section 5.14(a) Registration Statement Section 5.14(a) Representative Losses Section 10.01(f) Requisite Company Vote Section 3.02(a) Resolution Period Section 2.16(b)(ii) Review Period Section 2.16(b)(ii) Revised Closing Statement Section 2.16(b)(i) Termination Fee Section 9.02(a) Third Party Claim Section 8.05(a) SEC Section 4.01 Series A Preferred Stock Section 3.04(a) Series B Preferred Stock Section 3.04(a) Series C Preferred Stock Section 3.04(a) Shareholder Representative Group Preamble Shareholder Indemnitees Section 8.03 Shares Section 2.09(a) Signing Date Preamble Statement of Objections Section 2.16(b)(ii) Straddle Period Section 6.04 Surviving Corporation Section 2.1 Third Milestone 2.01 Tax Claim Section 2.10(g6.05 Undisputed Amounts Section 2.16(b)(iii) Third Milestone Payment Amount Union Section 2.10(g3.19(b) VBCA Recitals Working Capital Escrow Fund Section 2.12(a)(ii) Working Capital Shortfall Section 2.16(c)(iii)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below. Location of AAA Section hereof in which such term is defined: 12.5(c) Affiliates Section 7.17 Agreement Preamble Biogen Idec License Agreement of Merger Section 2.3 Xxxxxx Employment Agreement Section 4.7 Biogen Idec Supply Agreement 11.3(w) Basket Section 4.7 Books and Records 12.2(c)(i) CCC Recital B CERCLA Section 2.12(f)(2) Claim Notice Section 8.3(a12.2(c)(iii) Closing Section 2.3 2.2 Closing Date Section 2.3 2.2 Closing Date Severance Working Capital Section 3.11(a) Closing Date Working Capital Section 3.3(a) COBRA Section 7.14(e) Company Preamble Company 401(K) Plan Section 10.7(d) Company Board Recommendation Section 7.3(a) Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Recital A Company Indemnified Parties Section 8.2(a)(ii12.2(b) Contracts Company Indemnified Party Section 4.8(a12.2(b) Covered Company Indemnifying Parties Section 12.2(a) Company Indemnifying Party (PartiesSection 12.2(a) Contingent Purchase Price Payment Section 8.2(a)(ii3.4(d) CTS Section 11.3(v) Customers Section 7.11(a) Damage Payment Section 12.2(d) Damages Section 8.2(a)(i12.2(a) DGCL Determination Date Section 2.1 Document Retention Period 3.3(b) Disclosure Letter Article VII Dispute Notice Section 2.12(f)(23.4(b) Drug Regulatory Agency Dissenting Shareholder Section 4.25 3.6(a) Dissenting Shares Section 3.6(a) Effective Time Section 2.2 2.3 Environmental Law Section 7.18 ERISA Section 4.13(a7.14(a) ERISA Affiliate Section 4.13(a7.14(a) Finally Determined Escrow Section 8.5(b3.7(a) Escrow Agreement Section 3.7(a) Estimated Severance Working Capital Section 3.10 Estimated Severance Working Capital Statement Section 3.10 Estimated Working Capital Section 3.2 Estimated Working Capital Statement Section 3.2 Excess Payments Section 3.6(d) Expenses Section 10.6 Final Net Sales Statement Section 3.4(c) First Milestone Release Date Section 2.10(e3.7(a)(i) First Milestone Payment Amount GAAP Section 2.10(e7.4(b) Indemnifying Party Governmental Entity Section 8.3(a7.3(b) Instrument Hazardous Substance Section 2.12(c7.18 Insurance Policies Section 9.1 Intellectual Property Rights Section 7.19(a) Interim Balance Sheet Section 7.4(a) Interim Financial Statements Section 7.4(a) KLO Preamble KLO Agreement of Merger Section 2.1 4.3 KLO Board Recommendation Section 7.3(a) KLO Dissenting Shareholder Section 4.9(a) KLO Dissenting Shares Section 4.9(a) KLO Excess Payments Section 4.9(d) KLO Merger Certificate Recital D KLO Merger Effective Time Section 2.2 4.3 KLO Merger Sub Preamble KLO Required Shareholder Vote Section 7.12 KLO Surviving Entity Section 4.1 Liens Section 7.2(f) Material Agreement Section 7.13(a) Merger Recital B Merger Sub Preamble MT Recital E MT Payment Date Section 5.2(b) MT Purchase Agreement Section 5.1 MT Purchase Price Section 5.2(a) MT Stock Section 5.1 Net Sales Statement Section 3.4(a) Notice Section 12.3(a) Notice of Set-Off Dispute Section 3.5 Objection Notice Section 12.3(c) Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i12.2(a) parties Preamble Payee Parent Indemnified Party Section 8.5 Payor 12.2(a) Parent Indemnifying Parties Section 8.5 Per Diem 12.2(b) Parent Indemnifying Party Section 12.2(b) Parent Objection Notice Section 12.3(d) Percentage of Contingent Purchase Price Payment Section 3.4(d) Permits Section 7.8(a) Post-Closing Tax Period Section 9.2(d) Pre-Closing Return Section 9.2(d) Real Property Section 7.16(a) Required Shareholder Vote Section 7.12 Second Release Date Section 3.7(a)(ii) Seller Representative Letter Section 3.8(g) Selling Entity Employees Section 7.20(b) Set-Off Notice Section 3.5 Set-Off Review Period Section 3.5 Severance Working Capital Statement Section 3.11(a) Straddle Period Section 12.2(a)(vi) Surviving Entity Section 2.1 Tax Contest Section 9.2(d) Third Party Claim Section 12.4(a) Third Party Notice Section 12.4(a) Transfer Taxes Section 8.7(a9.2(e) Proceeding Violation Section 4.17 Royalties 7.3(c) Working Capital Statement Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g3.3(a)

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: Accounts Receivable Section 3.23(a) Additional Parent Filings Section 5.05(f) Affiliate Transactions Section 3.26(a) Agent Section 7.04(a) Agreed Claims Section 7.03(c) Agreement Preamble Biogen Idec License Agreement Alternative Acquisition Section 4.7 Biogen Idec Supply Agreement 5.01(f) Attorney Section 4.7 Books and Records 7.04(g) Bid Section 2.12(f)(23.19(a) Board Recitals Booked Revenue Section 3.09(e) Bridge Notes Section 2.04(b) Change in Recommendation Section 5.05(f) Claim Notice Section 8.3(a7.04(k) Claim Certificate Section 7.03(a) Closing Section 2.3 2.01(c) Closing Date Section 2.3 2.01(c) Closing Form 8-K Section 5.05(g) Closing Press Release Section 5.05(g) Collateral Source Section 7.02 Communication Policy Section 5.01(h) Company Preamble Company Common Stock Employee Benefit Plan Section 2.8 3.14(a) Company Disclosure Schedule Article IV Government Contract Section 3.19(a) Company Expenses Schedule Government Subcontract Section 2.13 3.19(a) Company Indemnified Parties Group Section 8.2(a)(ii8.15(a) Contracts Company Prepared Returns Section 4.8(a5.04(a) Covered Party (PartiesCompany Unitholder Approval Recitals Control Section 1.01 Copyrights Section 1.01 D&O Beneficiary Section 5.09(b) D&O Claim Section 8.2(a)(ii5.09(b) Damages D&O Provisions Section 8.2(a)(i5.09(a) DGCL Data Room Section 2.1 Document Retention Period 8.05 Deductible Section 2.12(f)(27.01(b) Drug Regulatory Agency Deposit Materials Section 4.25 2.02(b) Director Nomination Agreement Section 2.04(b) DLLCA Recitals Earn Out Shares Section 2.06(a) Effective Time Section 2.2 ERISA 2.01(d) Environmental Permits Section 4.13(a3.17 Eos Companies Interim Financial Statements Section 3.04(a) ERISA Affiliate Escrow Agent Section 4.13(a2.04(b) Finally Determined Excluded Units Section 8.5(b2.02(a)(ii) Financial Statements Section 3.04(a) First Milestone Certificate of Merger Section 2.10(e2.01(d) First Milestone Payment Amount Merger Recitals First Surviving Company Recitals Formula Section 2.10(e2.02(b) Indemnified Matters Section 7.01(a) Indemnified Persons Section 5.09(a) Indemnifying Party Section 8.3(a7.03(c) Instrument Intended Tax Treatment Recitals Internal Controls Section 2.12(c3.04(a) Merger IRS Section 2.1 Merger Certificate 3.14(a) Latest Balance Sheet Section 2.2 3.04(a) LTIP Section 5.01(e) Material Customer Section 3.09(c) Material Contract Section 3.09(b) Mergers Recitals Merger Sub I Preamble Merger Sub II Preamble New Customer Contracts Section 3.09(a) Newco Section 5.14(a) Newco Merger Sub Section 5.14(a) Non-Party Affiliate Section 5.11 Obligations Section 7.04(a) Ordinary Course of Business Section 8.05 Outside Date Section 6.01(c) Parent Preamble Parent Disclosure Schedule Article V Class A Common Section 4.05(a) Parent Indemnified Class B Common Section 4.05(a) Parent Warrants Section 4.05(a) Parent SEC Reports Section 4.08 Parent Stockholder Group Section 8.15 Party Preamble Patents Section 1.01 Permits Section 3.16(b) Pledged Collateral Section 7.04(a) Pledged Shares Section 7.04(a) Pledgor Section 7.04(a) Pre-Closing Period Section 5.01(a) Pre-Closing Reorganization Section 5.14(a) Privileged Communications Section 8.15 Purchaser Indemnitees Section 7.01(a) Registration Rights Agreement Section 2.04(b) Second Certificate of Merger Section 2.01(d) Second Effective Time Section 2.01(d) Second Merger Recitals Securityholder Representative Preamble Signing Press Release Section 5.05(b) Sponsor Section 2.04(b)(x) Sponsor Earn Out Agreement Section 2.04(b)(x) Trademarks Section 1.01 Transfer Taxes Section 5.04(e) Triggering Event Section 2.06(a) UCC Section 7.04(b) Ultimate Surviving Company Recitals Unitholder Letter of Transmission Section 2.03(b) Waiving Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)8.15

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: 401(k) Plan Section hereof in which such term is defined: 5.07(d) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 5.03(d)(i) Book-Entry Shares Section 4.7 Books and Records 2.02(b) Capitalization Date Section 2.12(f)(23.02(a) Claim Notice Certificate of Merger Section 8.3(a1.02 Certificates Section 2.02(b) Change of Board Recommendation Section 5.03(a)(iv) Closing Section 2.3 1.02 Closing Date Section 2.3 1.02 Company Preamble Company Common Stock Section 2.8 Board Recitals Company Board Recommendation Recitals Company Disclosure Schedule Article IV III Company Expenses Schedule Employees Section 2.13 5.07(a) Company Indemnified Parties Financial Statements Section 8.2(a)(ii3.07(a) Contracts Company Material Contract Section 4.8(a3.13(a) Covered Party (PartiesCompany Permits Section 3.05(a) Company Preferred Stock Section 8.2(a)(ii3.02(a) Damages Company Representatives Section 8.2(a)(i5.02(a) Company SEC Documents Section 3.06(a) Company Stockholder Approval Section 3.21 Confidentiality Agreement Section 5.02(c) D&O Indemnification Agreements Section 5.08(a) D&O Runoff Insurance Section 5.08(c) DGCL Recitals Dispute Section 2.1 Document Retention Period 3.15(l) Dissenting Shares Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 2.03 Effective Time Section 2.2 ERISA 1.02 Electronic Delivery Section 4.13(a8.13 Employment Practices Section 3.12(a) ERISA Affiliate Export Approvals Section 4.13(a3.05(e) Finally Determined Fundamental Representations Section 8.5(b6.02(a)(ii) First Milestone Guaranteed Obligations Section 2.10(e8.15(a) First Milestone Payment Guarantor Section 8.15(a) Guaranty Section 8.15(c) Indemnified Persons Section 5.08(a) Independent Director Section 3.12(f) Insurance Policies Section 3.17 Intercompany Contracts Section 3.13(a)(vii) Intervening Event Notice Period Section 5.03(e)(i) Leased Real Property Section 3.18(c) Maximum Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c5.08(c) Merger Section 2.1 Recitals Merger Certificate Section 2.2 Consideration Recitals Merger Sub Preamble Most Recent Balance Sheet Section 3.09(a)(i) New Plans Section 5.07(a) Parent Preamble Parent Disclosure Schedule Article V Representatives Section 5.02(a)(i) Parent Indemnified Parties Subsidiary Section 8.2(a)(i4.03(a) parties Preamble Payee Parent Welfare Plan Section 8.5 Payor 5.07(a) Paying Agent Section 8.5 Per Diem Taxes 2.02(a) Proxy Statement Section 8.7(a1.03(a) Proceeding PSU Award Section 4.17 Royalties 2.04(d) Replacement PSU Section 2.10(h2.04(d) Second Milestone Replacement RSU Section 2.10(f2.04(b) Second Milestone Payment Amount RSU Award Section 2.10(f2.04(b) Stockholder Consent Xxxxxxxx-Xxxxx Act Section 3.06(a) Section 16 Section 5.10 Shares Recitals Stockholder Representative Preamble Super Majority Significant Customer Section 2.12(b3.13(a)(xviii) Specified Antitrust Laws Section 6.01(b) Special Meeting Section 1.03(e) Superior Proposal Notice Period Section 5.03(d)(i) Surviving Corporation Recitals Takeover Law Section 2.1 Third Milestone 3.03(b) Termination Fee Section 2.10(g7.02(b) Third Milestone Payment Amount U.S. Continuing Employees Section 2.10(g5.07(b) WARN Act Section 3.12(d)

Terms Defined Elsewhere. The Solely for convenience, the following is a list of additional terms used that are defined in the section of this Agreement and a reference to the Section hereof in which set forth after each such term is definedbelow: Accounting Firm Section 3.2 Accounts Receivable Section 2.1(j) Agreement Preamble Biogen Idec License Agreement Allocation Schedule Section 4.7 Biogen Idec Supply Agreement 3.2 Alternate Debt Financing Section 4.7 7.18(c) Alternative Financing Commitment Section 7.18(c) Assumed Liabilities Section 2.3 Balance Sheet Date Section 5.6 Xxxx of Sale Section 4.2(a) Books and Records Section 2.12(f)(22.1(e) Business Related Software Section 5.14(b) Cash Purchase Price Section 3.1 Claim Notice Section 8.3(a10.4(a) Closing Section 2.3 4.1 Closing Date Section 2.3 4.1 Code Section 3.2 Company Cash Section 2.1(q) Comprint Preamble Company Common Stock Confidentiality Agreement Section 2.8 Company 7.4 Consents Section 5.5 Contract Section 2.1(g) Controversy Section 11.10 Disclosure Schedule Letter Article IV Company Expenses Schedule V Domain Name Assignment Section 2.13 Company Indemnified Parties Section 8.2(a)(ii4.2(c) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Exchange Act Article V Excluded Assets Section 2.2 ERISA Financial Statements Section 4.13(a5.6 Financing Section 6.4 Financing Commitment Section 6.4 Flex Plan Section 7.16(f) ERISA Affiliate Form 8594 Section 4.13(a3.2 Grant Deed Section 4.2(b) Finally Determined Guarantor Preamble Xxxxx-Xxxxx Xxxx and Logo Section 8.5(b2.2(f) First Milestone HH Shoppers Preamble Indemnified Party Section 2.10(e) First Milestone Payment Amount Section 2.10(e10.4(a) Indemnifying Party Section 8.3(a10.4(a) Instrument of Assignment and Xxxx of Sale Section 2.12(c4.2(a) Merger Inventory Section 2.1 Merger Certificate 2.1(i) Lease Assignment Section 2.2 Merger Sub Preamble 4.2(e) Leased Real Property Section 2.1(a)(ii) Licensed Software Section 5.14(b) Licenses and Permits Section 2.1(h) Machinery Section 2.1(c) Material Agreement Section 5.9(a) Natural Hazard Areas Section 11.20 Notice Section 11.10 Notice Period Section 10.4(c) Owned Real Property Section 2.1(a)(i) Parent Preamble Parent Disclosure Schedule Article V Benefit Plans Section 5.12 Parent Deductible Section 10.2(b)(i) Parent Indemnified Parties Section 8.2(a)(i10.3(a) parties Personal Property Leases Section 2.1(b) Party Preamble Payee Proprietary Software Section 8.5 Payor 5.14(b) Purchase Price Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation 3.1 Purchased Assets Section 2.1 Third Milestone Purchasers Preamble Purchasers Deductible Section 2.10(g10.3(b)(i) Third Milestone Payment Amount Purchasers Indemnified Parties Section 2.10(g10.2(a) Purchasers Plan Section 7.16(c) Purchasers Savings Plan Section 7.16(d) RE Purchaser Preamble Response Section 11.10 Retained Liabilities Section 2.4 Reverse Termination Fee Section 9.2 SEC Article V Sellers Preamble Software Section 5.14(b) Tax Refunds Section 2.2(b) Trademark Assignment Section 4.2(c) Transfer Tax Returns Section 7.8(a) Transferred Employees Section 7.16(a) Transferred Intellectual Property Section 2.1(d) Transition Services Agreement Section 4.2(d)